Estimaciones de analistas de Wall Street para Oxbridge Re Holdings Limited (OXBR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 1 |
| Mantener | 0 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 1 |
| Calificación media (1-5) | 1.00 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.06 | ||
| 2026-08-13 | $0.02 | $0.04 | -50.0% |
| 2026-05-11 | $0.00 | $-0.03 | +100.0% |
| 2026-03-30 | $0.02 | $-0.02 | +200.0% |
| 2025-11-06 | $-0.02 | $-0.01 | -100.0% |
| 2025-08-14 | $-0.25 | $-0.01 | -2400.0% |
| 2025-05-12 | $-0.02 | $-0.02 | +0.0% |
| 2025-03-26 | $-0.05 |
Ratios de valoración
| Ratio P/E | 90.50 |
| Precio / Valor contable | 0.60 |
| EV / EBITDA | -0.85 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $19.1M | $23.8M | $3.8M | $981000 | $1.2M | $10.2M | $850000 | -$7.0M | $546000 | $2.6M |
| Coste de Ventas | $15.1M | $43.1M | $10.3M | $64000 | $98000 | $264000 | $1.2M | $141000 | $254000 | $3.0M |
| Beneficio Bruto | $4.0M | -$19.3M | -$6.5M | $917000 | $1.1M | $10.0M | -$333000 | -$7.0M | $292000 | -$417000 |
| I+D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $1.4M | $1.3M | $1.3M | $1.1M | $1.0M | $1.3M | $1.4M | $2.2M | $1.9M | $3.0M |
| Gastos Operativos | $1.4M | $1.3M | $1.3M | $1.1M | $1.0M | $1.3M | $1.4M | $2.2M | $1.9M | $3.0M |
| Beneficio Operativo | $2.6M | -$20.6M | -$7.7M | -$150000 | $88000 | $8.7M | -$1.7M | -$9.2M | -$1.6M | -$3.5M |
| EBITDA | $2.6M | -$20.6M | -$7.7M | -$140000 | $98000 | $8.7M | -$1.7M | -$9.4M | -$1.6M | -$3.5M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | $2.6M | -$20.6M | -$7.7M | -$150000 | $88000 | $8.7M | -$1.7M | -$9.4M | -$1.6M | -$3.5M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $542000 | 0 | 0 |
| Beneficio Neto | $2.6M | -$20.6M | -$7.7M | -$150000 | $88000 | $8.7M | -$1.7M | -$9.9M | -$1.8M | -$3.5M |
| BPA | $0.43 | $-3.55 | $-1.00 | $-0.03 | $0.02 | $1.49 | $-0.61 | $-1.69 | $-0.45 | $-0.28 |
| BPA Diluido | $0.43 | $-3.55 | $-1.00 | $-0.03 | $0.02 | $1.49 | $-0.61 | $-1.69 | $-0.45 | $-0.28 |
| Acciones en Circulación (Diluidas) | $6.0M | $5.8M | $5.7M | $5.7M | $5.7M | $5.7M | $5.8M | $5.9M | $6.1M | $7.4M |
Precio
| Precio | $1.42 |
| Capitalización | $12M |
| Bolsa | NASDAQ |
| País | KY |
Empresas relacionadas: AIFU · CARV · CNF · FLD · GCMG · GSIW · MEGL
Explorar sector: Financial Services · Insurance - Reinsurance
Más secciones de OXBR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones